Dr. Tara Swart speaks with Charlotte Clarke of The Financial Times about her work and what inspired her to switch from working in medicine to business. “My mission is to disseminate simple, pragmatic neuroscience-based messages that change the way people work and that translate to tangible financial improvements in business,” says Swart of her work.
WBUR’s Deborah Becker and Lynn Jolicoeur report on the new MIT-MGH partnership aimed at developing better tools to treat disease. Prof. Arup Chakraborty hopes the collaboration will allow researchers to take risks. “Safe ideas are often not the transformative ones,” he says.
Nature highlights the top science news of the week, including the new interdisciplinary center at MIT aimed at examining the microbiome. “The center will initially focus on inflammatory bowel disease, but organizers hope to eventually broaden the scope to diseases such as multiple sclerosis, arthritis and autism,” Nature reports.
In a piece for The Atlantic, Sarah Laskow writes about how MIT researchers have developed a new drug-delivery capsule that could serve as an alternative to injections. The new drug capsule would make it possible to “deliver drugs that would otherwise break down in the digestive tract.”
Sacha Pfeiffer of WBUR speaks with Jonathan Eig, the author of a new book on the history of birth control, about the role of MIT alumna Katherine McCormick in the development of the birth control pill. McCormick, a pioneer of the women's suffrage movement, funded much of the research that led to the creation of the pill.
Melissa Malamut of Boston Magazine writes that MIT and MGH are forming a new partnership aimed at tackling challenges in clinical medicine. The new collaboration will address three specific areas: disease diagnosis, the prevention and treatment of infectious and autoimmune diseases, and the diagnosis and treatment of major neurodegenerative and psychiatric diseases.
Atlantic reporter Cari Romm reports on how MIT researchers have devised an alternative drug-delivery method: A pill covered with tiny needles. The researchers plan to improve their current design by creating a “fully biodegradable version of the pill.”
WCVB reports that researchers from MIT and Massachusetts General Hospital have developed a pill coated with tiny needles that can deliver drugs directly into the digestive tract. The pill was found to deliver insulin more efficiently than current methods, WCVB reports.
“Researchers at the Massachusetts Institute of Technology have developed a pill-like capsule that injects medication into the stomach lining after being swallowed,” reports Sky News. The new capsule could allow for oral delivery of drugs that currently must be injected.
Melissa Malamut of Boston Magazine writes that a team of MIT researchers has developed a new scaling law to estimate the risk of blast-induced traumatic brain injury. The new method could be useful in helping the military develop more protective helmets and in diagnosing traumatic brain injury, Malamut reports.
MIT scientists have developed a pill coated in tiny needles that allows medicine to be absorbed through the lining of the stomach, writes Brooks Hays of UPI. Initial trials showed that the pill delivered insulin more efficiently than an injection.
Thomas Burton of The Wall Street Journal writes that MIT researchers were among those awarded the first research grants under President Obama’s new BRAIN Initiative. Burton writes that one of the MIT grants will go toward “determining which exact brain circuits are involved in generating short-term memories that influence decisions.”
Boston Globe reporter Deborah Kotz writes that MIT researchers have been awarded new grants from the National Institutes of Health to further brain research. “Biophysicist Alan Jasanoff received a grant to develop imaging agents for functional MRI imaging that would target the flow of calcium into and out of brain cells,” writes Kotz of one of the MIT grants.
MIT neuroscientists were among the recipients of new grants for brain research from the National Institutes of Health, reports Jon Hamilton for NPR. Hamilton explains that as part of one grant, “Researchers from the Massachusetts Institute of Technology will try to adapt functional MRI so that it can show the activity of individual brain cells.”
The Boston Globe writes about Professor Sangeeta Bhatia's commitment to mentoring her students. “It's heartening to know that, tucked away in labs all over our region, solution-driven scientists like Sangeeta Bhatia are tinkering and building — and encouraging others to do the same.”